ENSACOVE
Live / Applied — Statement of use — registration review complete (as of 23 Mar 2026)
What this means for you
Not registered yet, but its 27 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97812894
- Mark type
- Stylized text
- Filed
- 27 Feb 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: therapeutic pharmaceuticals and agents for the treatment of disease, namely, cancer; pharmaceutical preparations and agents for the treatment of cancer; pharmaceutical preparations and agents used to inhibit kinase for use in the treatment of cancer
Owner
- Xcovery Holdings, Inc., Palm Beach Gardens, FL, US
- Xcovery Holdings, Inc., Palm Beach Gardens, FL, US
Prosecution history
- 23 Mar 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 23 Mar 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Sept 2025 — USE AMENDMENT FILED
- 12 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Sept 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Mar 2025 — SOU EXTENSION 2 GRANTED
- 05 Mar 2025 — SOU EXTENSION 2 FILED
- 05 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2024 — SOU EXTENSION 1 GRANTED
- 04 Sept 2024 — SOU EXTENSION 1 FILED
- 04 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Mar 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT